Beta‐Catenin‐Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI : A Systematic Review and Meta‐Analysis
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.29279 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Luyao Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Liver Neoplasms, Adenoma, Liver Cell, beta Catenin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Bayer HealthCare Investigator Initiated Research, Bayer HealthCare.
Abstract (Originalsprache)
Background
Beta‐catenin‐mutated hepatocellular adenomas (β‐HCAs) can appear iso‐ to hyperintense at the hepatobiliary phase (HBP) at magnetic resonance imaging (MRI). Given the relatively lower prevalence of β‐HCAs, prior studies had limited power to show statistically significant differences in the HBP signal intensity between different subtypes.
Purpose
To assess the diagnostic performance of HBP MRI to discriminate β‐HCA from other subtypes. Study Type Systemic review and meta‐analysis. Population Ten original studies were included, yielding 266 patients with 397 HCAs (9%, 36/397 β‐HCAs and 91%, 361/397 non‐β‐HCAs). Field Strength/Sequence 1.5 T and 3.0 T, HBP. Assessment PubMed, Web of Science, and Embase databases were searched from January 1, 2000, to August 31, 2023, for all articles reporting HBP signal intensity in patients with histopathologically proven HCA subtypes. QUADAS‐2 was used to assess risk of bias and concerns regarding applicability. Statistical Tests Univariate random‐effects model was used to calculate pooled estimates. Heterogeneity estimates were assessed with I 2 heterogeneity index. Meta‐regression (mixed‐effect model) was used to test for differences in the prevalence of HBP signal between HCA groups. The threshold for statistical significance was set at P < 0.05.
Results
HBP iso‐ to hyperintensity was associated with β‐HCAs (pooled prevalence was 72.3% in β‐HCAs and 6.3% in non‐β‐HCAs). Pooled sensitivity and specificity were 72.3% (95% confidence interval 54.1–85.3) and 93.7% (93.8–97.7), respectively. Specificity had substantial heterogeneity with I 2 of 83% due to one study, but not for sensitivity ( I 2 = 0). After excluding this study, pooled sensitivity and specificity were 77.4% (59.6–88.8) and 94.1% (88.9–96.9), with no substantial heterogeneity. One study had high risk of bias for patient selection and two studies were rated unclear for two domains. Data Conclusion Iso‐ to hyperintensity at HBP MRI may help to distinguish β‐HCA subtype from other HCAs with high specificity. However, there was heterogeneity in the pooled estimates. Level of Evidence 3 Technical Efficacy Stage 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Luyao Shen, Justin R Tse
Förderung
- Bayer HealthCare Investigator Initiated Research
- Bayer HealthCare
Zitieren
APA
Shen, L., Altmayer, S., & Tse, J. R. (2024). Beta‐Catenin‐Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI : A Systematic Review and Meta‐Analysis. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29279
Vancouver
Shen L, Altmayer S, Tse JR. Beta‐Catenin‐Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI : A Systematic Review and Meta‐Analysis. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29279
BibTeX
@article{Shen2024,
author = {Shen, Luyao and Altmayer, Stephan and Tse, Justin R},
title = {Beta‐Catenin‐Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI : A Systematic Review and Meta‐Analysis},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.29279}
}
EUVIMED